Alpana Loomba, MSc., has served as Senior Vice President, Development Operations at Nurix since May 2024. Ms. Loomba has over 25 years of experience in drug development across several indications including hematology-oncology, infectious disease, and organ transplantation and has worked on fifteen drug products that have received FDA or international regulatory approval in North America, the EU and APAC. During her career, she has worked in development operations serving in positions of increasing responsibility at Merck, Schering-Plough, Zeneca, Roche, Portola Pharmaceuticals, Gilead Sciences and most recently at Allogene Therapeutics. Ms. Loomba holds a BSc. and MSc.in Food and Nutrition from the Lady Irwin College, Delhi University, India, and she started her research career at Johns Hopkins University.
'